402 related articles for article (PubMed ID: 33585240)
1. Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments.
Gómez-Oliva R; Domínguez-García S; Carrascal L; Abalos-Martínez J; Pardillo-Díaz R; Verástegui C; Castro C; Nunez-Abades P; Geribaldi-Doldán N
Front Oncol; 2020; 10():614295. PubMed ID: 33585240
[TBL] [Abstract][Full Text] [Related]
2. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
4. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
5. Development of glioblastoma organoids and their applications in personalized therapy.
Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
[TBL] [Abstract][Full Text] [Related]
6. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
[TBL] [Abstract][Full Text] [Related]
7. Rapid 3D Bioprinting of Glioblastoma Model Mimicking Native Biophysical Heterogeneity.
Tang M; Tiwari SK; Agrawal K; Tan M; Dang J; Tam T; Tian J; Wan X; Schimelman J; You S; Xia Q; Rana TM; Chen S
Small; 2021 Apr; 17(15):e2006050. PubMed ID: 33502104
[TBL] [Abstract][Full Text] [Related]
8. Bioprinting of glioma stem cells improves their endotheliogenic potential.
Wang X; Li X; Dai X; Zhang X; Zhang J; Xu T; Lan Q
Colloids Surf B Biointerfaces; 2018 Nov; 171():629-637. PubMed ID: 30107336
[TBL] [Abstract][Full Text] [Related]
9. Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.
Sang Y; Hou Y; Cheng R; Zheng L; Alvarez AA; Hu B; Cheng SY; Zhang W; Li Y; Feng H
Neuro Oncol; 2019 Nov; 21(11):1423-1435. PubMed ID: 31232447
[TBL] [Abstract][Full Text] [Related]
10. Vascularization ability of glioma stem cells in different three-dimensional microenvironments.
Wang X; Xu T; Niu C
Regen Biomater; 2024; 11():rbad094. PubMed ID: 38173775
[TBL] [Abstract][Full Text] [Related]
11. Brain-Tumor-Regenerating 3D Scaffold-Based Primary Xenograft Models for Glioma Stem Cell Targeted Drug Screening.
Jeena K; Manju CA; Sajesh KM; Gowd GS; Sivanarayanan TB; Mol C D; Manohar M; Nambiar A; Nair SV; Koyakutty M
ACS Biomater Sci Eng; 2019 Jan; 5(1):139-148. PubMed ID: 33405881
[TBL] [Abstract][Full Text] [Related]
12. Pam
Megías J; Martínez A; San-Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Albert-Bellver D; Carratalá A; Gozalbo D; López-Ginés C; Gil ML; Cerdá-Nicolás M
Invest New Drugs; 2020 Apr; 38(2):299-310. PubMed ID: 31076963
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.
Persano L; Rampazzo E; Basso G; Viola G
Biochem Pharmacol; 2013 Mar; 85(5):612-622. PubMed ID: 23063412
[TBL] [Abstract][Full Text] [Related]
14. A novel neuronal organoid model mimicking glioblastoma (GBM) features from induced pluripotent stem cells (iPSC).
Hwang JW; Loisel-Duwattez J; Desterke C; Latsis T; Pagliaro S; Griscelli F; Bennaceur-Griscelli A; Turhan AG
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129540. PubMed ID: 31978452
[TBL] [Abstract][Full Text] [Related]
15. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
16. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Glioblastoma Models: A Journey into the Third Dimension.
Paolillo M; Comincini S; Schinelli S
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070023
[TBL] [Abstract][Full Text] [Related]
18. 3D bioprinting of glioblastoma models.
Parra-Cantu C; Li W; Quiñones-Hinojosa A; Zhang YS
J 3D Print Med; 2020 Jun; 4(2):113-125. PubMed ID: 33200034
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
[TBL] [Abstract][Full Text] [Related]
20. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
